|12 Months Ended|
Dec. 31, 2021
Schedule of other (expenses) income
Grant income received in the years ended December 31, 2021 and 2020 was represented by payments under the Coronavirus Job Retention Scheme. Grant income received in the year ended December 31, 2019 was represented by research and development related grant funding.
Unrealized exchange differences in the period relate to retranslation of the US dollar denominated convertible loan notes as at the period end.
Other income includes research and development tax credits totaling £Nil (2020: £6,772 and 2019: £394,642).
TC BIOPHARM (HOLDINGS) PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
The disclosure of other operating income or expense. [Refer: Other operating income (expense)]
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef